Related Experiment Videos
Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis
A K Short1, C M Lockwood, A Bollen
1Department of Medicine, School of Clinical Medicine, University of Cambridge, UK.
Abstract:
Myeloperoxidase (MPO) is one of the major autoantigens recognized by anti-neutrophil cytoplasm antibodies. The association of this antigen with specific disease entities requires that there is a source of pure antigen present in large quantities. Further delineation of the molecular mechanisms involved in the antigen-antibody interaction requires the ability to manipulate the molecule. The expression of recombinant MPO in Chinese hamster ovary cells has produced a source of pure protein, suitable for molecular studies. We have shown that this protein is an antigen recognized by 95% of anti-MPO antibodies from patients with systemic vasculitis. This recombinant molecule will be of use in providing an additional specific solid-phase assay for these antibodies and further forms of this protein which mirror the antigenicity of native MPO more exactly may replace chemically purified antigen. It will also be of great value in studies examining the epitopes recognized by anti-MPO antibodies and in studies of immunoregulation and T cell activation.
Insights
Researchers produced pure recombinant myeloperoxidase (MPO) in hamster cells. This pure MPO is recognized by 95% of anti-MPO antibodies in patients with systemic vasculitis, aiding disease research.
Area of Science:
- Immunology
- Biochemistry
Background:
- Myeloperoxidase (MPO) is a key autoantigen targeted by anti-neutrophil cytoplasm antibodies.
- Pure MPO is essential for understanding its association with specific diseases and antigen-antibody interactions.
Purpose of the Study:
- To produce a pure source of MPO for molecular and immunological studies.
- To evaluate the antigenicity of recombinant MPO against patient-derived antibodies.
Main Methods:
- Recombinant MPO was expressed in Chinese hamster ovary (CHO) cells.
- The purified recombinant MPO was tested against anti-MPO antibodies from patients with systemic vasculitis.
Main Results:
- Recombinant MPO was successfully produced as a pure protein source.
- This recombinant MPO was recognized by 95% of anti-MPO antibodies from patients with systemic vasculitis.
Conclusions:
- Recombinant MPO provides a pure, manipulable antigen for molecular studies.
- It can be used in specific assays for anti-MPO antibodies and for epitope mapping in systemic vasculitis.